RocketVax
RocketVax is a biotech company that develops novel vaccines by incorporating molecular and DNA-based technology.
Basel, Switzerlandrocketvax.com ↗
Total raised
€6.7M
€6,711,416
Funding rounds
1
Investors
3
distinct backers
Active since
2021-08
latest 2021-08
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood16
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-08-05 | Series A | €6.7M | Canton of Basel-Stadt,Innosuisse,University Hospital Basel | View deal → |
Related news
- RocketVax raises CHF 7.2 million to advance clinical studies for its COVID 19 vaccinestartupticker.ch · 2021-08
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy